These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20081589)

  • 21. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
    Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of thromboembolism in pregnancy.
    Marks PW
    Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Are there guidelines for performance of coloscopy during drug anticoagulation?].
    Vogt W; Maier KP
    Dtsch Med Wochenschr; 2003 Oct; 128(44):2333. PubMed ID: 14593580
    [No Abstract]   [Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia: a complication of thromboprophylaxis.
    Kejariwal D
    J Bone Joint Surg Br; 2006 Mar; 88(3):392-3. PubMed ID: 16498019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low molecular weight heparins: practical considerations.
    Kessler CM
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):35-42. PubMed ID: 9399408
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comment requested by the editorial staff].
    Haas S
    Chirurg; 2002 Dec; 73(12):1204. PubMed ID: 12617084
    [No Abstract]   [Full Text] [Related]  

  • 27. Skin necrosis is a clinical manifestation of low-molecular weight heparin-induced thrombocytopenia.
    Fontana P; Bodmer A; Gruel Y; Boehlen F; Janer V; Kaya G; Righini M
    Thromb Haemost; 2004 Jan; 91(1):196-7. PubMed ID: 14691586
    [No Abstract]   [Full Text] [Related]  

  • 28. The incidence and clinical features of heparin-induced thrombocytopenia.
    Bartholomew JR
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S3-8. PubMed ID: 16105557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

  • 30. Heparin induced thrombocytopenia after low molecular weight heparin treatment: a case report.
    Illuminati G; Caliò FG; Bertagni A; Forte A; Gallinaro L; Montesano G; Ciulli A
    Riv Eur Sci Med Farmacol; 1996; 18(5-6):225-8. PubMed ID: 9177626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism.
    Stein PD; Hull RD; Matta F; Yaekoub AY; Liang J
    Am J Med; 2009 Oct; 122(10):919-30. PubMed ID: 19682670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of heparin-induced thrombocytopenia and thrombosis.
    Green RM
    Semin Vasc Surg; 1996 Dec; 9(4):292-5. PubMed ID: 8958605
    [No Abstract]   [Full Text] [Related]  

  • 33. [Heparin-associated thrombocytopenia (HAT) type II. An underestimated complication in prevention of thromboembolism with heparin].
    Oberst M; Vierling P; Thielemann F
    Chirurg; 1998 Feb; 69(2):198-203. PubMed ID: 9551270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heparin-induced thrombocytopenia in patients on hemodialysis].
    Matsuo T
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():312-8. PubMed ID: 15250315
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
    Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T
    Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-molecular-weight heparin in oncology.
    Zacharski LR; Loynes JT
    Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current use of low molecular weight heparins.
    Donayre CE
    Semin Vasc Surg; 1996 Dec; 9(4):362-71. PubMed ID: 8958613
    [No Abstract]   [Full Text] [Related]  

  • 39. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
    Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia: acknowledging its presence in low-molecular weight heparin therapy.
    Ng HJ; Lee LH
    Int J Hematol; 2003 Feb; 77(2):185-7. PubMed ID: 12627856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.